Moderna, Inc. Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 222,365 | 3,162,030 | 666,044 | |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 12.21 | 18,635 | 227,533 | 55,909 | |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 51.13 | 241,000 | 12,322,330 | 1,202,510 | 1.4 M to 1.2 M (-16.70 %) |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 12.21 | 18,635 | 227,533 | 1,443,510 | 1.4 M to 1.4 M (+1.31 %) |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 222,365 | 3,162,030 | 1,424,875 | 1.2 M to 1.4 M (+18.49 %) |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 14.22 | 42,570 | 605,345 | 117,980 | |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 82,474 | 1,007,008 | 263,760 | |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 66.54 | 125,044 | 8,320,428 | 0 | 125 K to 0 (-100.00 %) |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 82,474 | 1,007,008 | 125,044 | 42.6 K to 125 K (+193.74 %) |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 14.22 | 42,570 | 605,345 | 42,570 | 0 to 42.6 K |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 66.11 | 200 | 13,222 | 1,996,540 | 2 M to 2 M (-0.01 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.94 | 800 | 51,952 | 1,996,740 | 2 M to 2 M (-0.04 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 63.97 | 1,000 | 63,970 | 1,997,540 | 2 M to 2 M (-0.05 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 62.54 | 1,910 | 119,451 | 1,998,540 | 2 M to 2 M (-0.10 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 61.61 | 3,763 | 231,838 | 2,000,450 | 2 M to 2 M (-0.19 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 60.77 | 1,182 | 71,830 | 2,004,213 | 2 M to 2 M (-0.06 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 58.72 | 100 | 5,872 | 2,005,395 | 2 M to 2 M (0.00 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 57.75 | 1,045 | 60,349 | 2,005,495 | 2 M to 2 M (-0.05 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 10,746 | 754,113 | 6,420,766 | 6.4 M to 6.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 69,254 | 4,809,448 | 6,431,512 | 6.5 M to 6.4 M (-1.07 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 56,406 | 3,958,353 | 21,986,399 | 22 M to 22 M (-0.26 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 363,594 | 25,250,331 | 22,042,805 | 22.4 M to 22 M (-1.62 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 367 | 26,584 | 6,500,766 | 6.5 M to 6.5 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 2,551 | 182,433 | 6,501,133 | 6.5 M to 6.5 M (-0.04 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 3,900 | 274,780 | 6,503,684 | 6.5 M to 6.5 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 7,443 | 512,185 | 6,507,584 | 6.5 M to 6.5 M (-0.11 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 23,199 | 1,557,822 | 6,515,027 | 6.5 M to 6.5 M (-0.35 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 42,540 | 2,797,690 | 6,538,226 | 6.6 M to 6.5 M (-0.65 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 1,933 | 140,017 | 22,406,399 | 22.4 M to 22.4 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 13,408 | 958,861 | 22,408,332 | 22.4 M to 22.4 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 20,492 | 1,443,793 | 22,421,740 | 22.4 M to 22.4 M (-0.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 39,082 | 2,689,404 | 22,442,232 | 22.5 M to 22.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 121,771 | 8,176,971 | 22,481,314 | 22.6 M to 22.5 M (-0.54 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 223,314 | 14,686,491 | 22,603,085 | 22.8 M to 22.6 M (-0.98 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 70.45 | 28 | 1,973 | 585,454 | 585.5 K to 585.5 K (0.00 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 69.69 | 3,277 | 228,374 | 585,482 | 588.8 K to 585.5 K (-0.56 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 68.74 | 6,503 | 447,016 | 588,759 | 595.3 K to 588.8 K (-1.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 67.76 | 1,238 | 83,887 | 595,262 | 596.5 K to 595.3 K (-0.21 %) |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 14.85 | 64,000 | 950,400 | 463,522 | |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 70.00 | 64,000 | 4,480,000 | 0 | 64 K to 0 (-100.00 %) |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 14.85 | 64,000 | 950,400 | 64,000 | 0 to 64 K |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 112,481 | 1,373,393 | 346,234 | |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 12,563 | 153,394 | 45,879 | |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 78.16 | 125,044 | 9,773,439 | 0 | 125 K to 0 (-100.00 %) |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 112,481 | 1,373,393 | 125,044 | 12.6 K to 125 K (+895.34 %) |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 12,563 | 153,394 | 12,563 | 0 to 12.6 K |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 12.21 | 211,978 | 2,588,251 | 74,544 | |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 29,022 | 412,693 | 888,409 | |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 86.96 | 798 | 69,394 | 1,202,510 | 1.2 M to 1.2 M (-0.07 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 86.54 | 2,600 | 225,004 | 1,203,308 | 1.2 M to 1.2 M (-0.22 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 85.16 | 5,868 | 499,719 | 1,205,908 | 1.2 M to 1.2 M (-0.48 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 84.27 | 33,792 | 2,847,652 | 1,211,776 | 1.2 M to 1.2 M (-2.71 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 83.33 | 59,175 | 4,931,053 | 1,245,568 | 1.3 M to 1.2 M (-4.54 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 82.28 | 56,379 | 4,638,864 | 1,304,743 | 1.4 M to 1.3 M (-4.14 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 81.43 | 16,736 | 1,362,812 | 1,361,122 | 1.4 M to 1.4 M (-1.21 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 80.24 | 35,569 | 2,854,057 | 1,377,858 | 1.4 M to 1.4 M (-2.52 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 79.40 | 18,675 | 1,482,795 | 1,413,427 | 1.4 M to 1.4 M (-1.30 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 77.48 | 7,640 | 591,947 | 1,432,102 | 1.4 M to 1.4 M (-0.53 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 76.45 | 3,768 | 288,064 | 1,439,742 | 1.4 M to 1.4 M (-0.26 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 12.21 | 211,978 | 2,588,251 | 1,443,510 | 1.2 M to 1.4 M (+17.21 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 29,022 | 412,693 | 1,231,532 | 1.2 M to 1.2 M (+2.41 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 66.68 | 2,243 | 149,563 | 1,202,510 | 1.2 M to 1.2 M (-0.19 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 66.05 | 9,715 | 641,676 | 1,204,753 | 1.2 M to 1.2 M (-0.80 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 64.96 | 5,442 | 353,512 | 1,214,468 | 1.2 M to 1.2 M (-0.45 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 63.80 | 2,600 | 165,880 | 1,219,910 | 1.2 M to 1.2 M (-0.21 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 66.90 | 700 | 46,830 | 596,500 | 597.2 K to 596.5 K (-0.12 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 66.11 | 5,809 | 384,033 | 597,200 | 603 K to 597.2 K (-0.96 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 65.06 | 2,937 | 191,081 | 603,009 | 605.9 K to 603 K (-0.48 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 63.91 | 1,600 | 102,256 | 605,946 | 607.5 K to 605.9 K (-0.26 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 1,577 | 0 | 6,739,044 | 6.7 M to 6.7 M (-0.02 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 66.26 | 700 | 46,382 | 2,006,540 | 2 M to 2 M (-0.03 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.46 | 1,700 | 109,582 | 2,007,240 | 2 M to 2 M (-0.08 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 65.28 | 1,674 | 109,279 | 2,008,940 | 2 M to 2 M (-0.08 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 62.94 | 726 | 45,694 | 2,010,614 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 60.77 | 200 | 12,154 | 2,011,340 | 2 M to 2 M (-0.01 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 66.69 | 100 | 6,669 | 2,011,540 | 2 M to 2 M (0.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 65.80 | 735 | 48,363 | 2,011,640 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.82 | 2,382 | 154,401 | 2,012,375 | 2 M to 2 M (-0.12 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.16 | 900 | 57,744 | 2,014,757 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 62.68 | 883 | 55,346 | 2,015,657 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 127,500 | 1,556,775 | 684,822 | |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 66.89 | 1,300 | 86,957 | 0 | 1.3 K to 0 (-100.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 66.27 | 15,640 | 1,036,463 | 1,300 | 16.9 K to 1.3 K (-92.33 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 65.28 | 46,517 | 3,036,630 | 16,940 | 63.5 K to 16.9 K (-73.30 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 64.44 | 38,089 | 2,454,455 | 63,457 | 101.5 K to 63.5 K (-37.51 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 63.17 | 16,183 | 1,022,280 | 101,546 | 117.7 K to 101.5 K (-13.75 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 62.41 | 8,371 | 522,434 | 117,729 | 126.1 K to 117.7 K (-6.64 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 61.16 | 1,400 | 85,624 | 126,100 | 127.5 K to 126.1 K (-1.10 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 127,500 | 1,556,775 | 127,500 | 0 to 127.5 K |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 125,044 | 1,526,787 | 58,442 | |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 62.65 | 17,744 | 1,111,662 | 0 | 17.7 K to 0 (-100.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 63.59 | 19,817 | 1,260,163 | 17,744 | 37.6 K to 17.7 K (-52.76 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 64.72 | 59,913 | 3,877,569 | 37,561 | 97.5 K to 37.6 K (-61.47 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 65.46 | 25,905 | 1,695,741 | 97,474 | 123.4 K to 97.5 K (-21.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 66.43 | 1,365 | 90,677 | 123,379 | 124.7 K to 123.4 K (-1.09 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 67.23 | 300 | 20,169 | 124,744 | 125 K to 124.7 K (-0.24 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 125,044 | 1,526,787 | 125,044 | 0 to 125 K |
May 14 2020 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Sell | S | 66.00 | 30,000 | 1,980,000 | 14,344 | 44.3 K to 14.3 K (-67.65 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 2,281,179 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,610,000 | 0 | 6,580,766 | 8.2 M to 6.6 M (-19.66 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 8,390,000 | 0 | 22,826,399 | 31.2 M to 22.8 M (-26.88 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | J | 0.00 | 55,568 | 0 | 6,740,621 | 6.7 M to 6.7 M (+0.83 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.57 | 6,751 | 402,157 | 7,893,252 | 7.9 M to 7.9 M (-0.09 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.57 | 3,376 | 201,108 | 9,202,903 | 9.2 M to 9.2 M (-0.04 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.57 | 3,376 | 201,108 | 6,685,053 | 6.7 M to 6.7 M (-0.05 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.20 | 2,109 | 124,853 | 607,546 | 609.7 K to 607.5 K (-0.35 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 58.39 | 2,131 | 124,429 | 609,655 | 611.8 K to 609.7 K (-0.35 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 57.13 | 1,200 | 68,556 | 611,786 | 613 K to 611.8 K (-0.20 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 56.07 | 849 | 47,603 | 612,986 | 613.8 K to 613 K (-0.14 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 55.04 | 2,887 | 158,900 | 613,835 | 616.7 K to 613.8 K (-0.47 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 54.11 | 970 | 52,487 | 616,722 | 617.7 K to 616.7 K (-0.16 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 52.84 | 900 | 47,556 | 617,692 | 618.6 K to 617.7 K (-0.15 %) |
May 06 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 50.48 | 4,770 | 240,790 | 0 | 4.8 K to 0 (-100.00 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 25,000 | 305,250 | 812,322 | |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 49.69 | 3,934 | 195,480 | 0 | 3.9 K to 0 (-100.00 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 48.87 | 3,984 | 194,698 | 3,934 | 7.9 K to 3.9 K (-50.32 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 47.82 | 10,784 | 515,691 | 7,918 | 18.7 K to 7.9 K (-57.66 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 46.91 | 6,298 | 295,439 | 18,702 | 25 K to 18.7 K (-25.19 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 25,000 | 305,250 | 25,000 | 0 to 25 K |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 4,349 | 211,796 | 9,206,279 | 9.2 M to 9.2 M (-0.05 %) |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 8,698 | 423,593 | 7,900,003 | 7.9 M to 7.9 M (-0.11 %) |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 11,046 | 537,940 | 618,592 | 629.6 K to 618.6 K (-1.75 %) |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 4,349 | 211,796 | 6,688,429 | 6.7 M to 6.7 M (-0.06 %) |
May 01 2020 | MRNA | Moderna, Inc. | Horning Sandra | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
May 01 2020 | MRNA | Moderna, Inc. | Horning Sandra | Director | Option Exercise | A | 46.37 | 17,195 | 797,332 | 17,195 |